DCM Shriram Fine Chemicals appoints Anil Kumar Khaitan as independent director
- Anil Kumar Khaitan appointed as non-executive independent director
- Five-year term effective September 4, 2026, subject to shareholder approval
- Brings 48 years of experience across pharma, steel, and jute sectors
- Appointment approved by Board on September 3, 2026

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals Ltd has appointed Anil Kumar Khaitan as an additional non-executive independent director. The appointment is effective September 4, 2026, and is subject to shareholder approval.
The Board of Directors approved the induction during its meeting held on September 3, 2026. The decision was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Appointment Details
Mr. Khaitan will serve a term of five consecutive years, from September 4, 2026, to September 3, 2031. The Nomination and Remuneration Committee recommended his appointment to the Board.
| Particulars | Details |
|---|---|
| Name | Anil Kumar Khaitan |
| DIN | 00759951 |
| Category | Non-Executive Independent Director |
| Term Start | September 4, 2026 |
| Term End | September 3, 2031 |
Profile and Experience
Mr. Khaitan, aged 70, is the Chairman of SNK Corp. He holds a B.Com degree and an MBA from IMI, Geneva (1981). He joined his family business in 1976.
He brings 48 years of diversified business experience across the jute, paper, pharmaceutical, copper, and steel industries, including international operations. His expertise includes strategic business planning, financial management, and human resource development.
Mr. Khaitan is a past President of PHD CCI and has served on the executive committees of FICCI and ASSOCHAM. He is also Chairman of the Governing Board of the ICSI Registered Valuers Organization.
Regulatory Compliance
The company confirmed that none of the existing directors are related to Mr. Khaitan. He is not debarred from holding office under any SEBI order or authority directive.
Historical Stock Returns for DCM Shriram Fine Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.87% | +0.65% | +4.58% | -9.67% | 0.0% | 0.0% |
How might Mr. Khaitan's extensive experience in pharmaceuticals and steel influence DCM Shriram's strategic diversification or supply chain resilience?
What specific governance reforms or board committee assignments are anticipated for Mr. Khaitan given his background in valuation and industry leadership?
Could this appointment signal an upcoming shift in DCM Shriram's capital allocation strategy or M&A activities under new board oversight?


































